The Prostate · 1995 · 56 citations · 20 references
MedicineMolecular GeneticsOncologyCancer GeneticsCarcinogenesisMolecular OncologyProstate CancerProstate PathologyProstatic PathologyTumor Suppressor GenesMissense MutationsP53 MutationPoint MutationsProstate AdenocarcinomaProstate CarcinogenesisProstatic AdenocarcinomaTumor Suppressor Gene MutationsTumor Suppressor P53
The genetic background underlying the growth and development of human prostatic cancer is not yet clear. Here we searched for possible mutations in the entire coding region of tumor suppressor gene p53 in primary human prostatic carcinomas, using polymerase chain reaction and single-strand conformational polymorphism analysis of RNA. We found p53 gene mutations in 4 of 21 cases (19%). DNA sequencing of the polymerase chain reaction products revealed missense point mutations that resulted in amino acid changes in exon 5 or 3 in three cases and single base deletions in exon 7 in two cases. One case contained both a missense point mutation and a single base deletion. Three of these four cases were pathologically diagnosed as poorly differentiated adenocarcinomas, and three of the four cases were clinically localized to stage C or D. None of seven noncancerous prostate tissues nor three well-differentiated adenocarcinoma tissues showed any mutations. The present results suggest that p53 gene mutation is involved in the late progression steps of human prostate carcinogenesis.
20
Mutations in the p53 gene occur in diverse human tumour types
Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature · 1989 · 2.8K citations · Full text
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Ih‐Chang Hsu, Robert A. Metcalf, Tai‐ping Sun et al. · Nature · 1991 · 1.5K citations